武警医学
武警醫學
무경의학
MEDICAL JOURNAL OF THE CHINESE PEOPLE'S ARMED POLICE FORCES
2014年
7期
728-732
,共5页
钟兴国%龚仁华%孙登群%曹葆强%范育林%姜世涛%蔡军%何新苗%骆会来
鐘興國%龔仁華%孫登群%曹葆彊%範育林%薑世濤%蔡軍%何新苗%駱會來
종흥국%공인화%손등군%조보강%범육림%강세도%채군%하신묘%락회래
肝癌%多药耐药%多柔比星%细胞系模型
肝癌%多藥耐藥%多柔比星%細胞繫模型
간암%다약내약%다유비성%세포계모형
hepatocellular carcinoma%multidrug resistance%doxorubicin%cell line model
目的:比较体外浓度梯度递增诱导和裸鼠肝脏移植诱导两种方法建立人肝癌多药耐药细胞系Bel-7402/多柔比星( Doxorubicin ,DOX)模型的生物学特性。方法分别采用体外浓度梯度递增诱导和裸鼠肝脏移植诱导建立人肝癌多柔比星多药耐药细胞亚系Bel-7402/DOXV 和Bel-7402/DOXL 后,利用相差显微镜观察细胞,MTT法检测两种细胞的耐药性,细胞计数法绘制生长曲线并用公式法计算倍增时间,流式细胞仪测定细胞DOX的摄入和外排以及P糖蛋白( P-gp)、多药耐药相关蛋白(MRP)、谷胱甘肽硫转酶系统(GSH/GST)的表达。结果两组耐药细胞Bel-7402/DOXV 和Bel-7402/DOXL 对DOX、CD-DP均产生了交叉耐药性,较亲本Bel-7402 IC50值差异有统计学意义(P<0.01);较亲本细胞的倍增时间明显延长,分别为65 h和46 h;较亲本的DOX外排率明显升高,分别为81.06%、66.56%;两组耐药细胞P-gp、MRP表达较亲本细胞显著提高( P<0.01),而GSH/GST的表达无明显变化。结论两种方法建立的耐药细胞系模型均有稳定的耐药性。肝脏移植法更能高度模拟人肝癌,它是具有近似人肝癌生物学和抗癌药物动力学特征的较理想模型。
目的:比較體外濃度梯度遞增誘導和裸鼠肝髒移植誘導兩種方法建立人肝癌多藥耐藥細胞繫Bel-7402/多柔比星( Doxorubicin ,DOX)模型的生物學特性。方法分彆採用體外濃度梯度遞增誘導和裸鼠肝髒移植誘導建立人肝癌多柔比星多藥耐藥細胞亞繫Bel-7402/DOXV 和Bel-7402/DOXL 後,利用相差顯微鏡觀察細胞,MTT法檢測兩種細胞的耐藥性,細胞計數法繪製生長麯線併用公式法計算倍增時間,流式細胞儀測定細胞DOX的攝入和外排以及P糖蛋白( P-gp)、多藥耐藥相關蛋白(MRP)、穀胱甘肽硫轉酶繫統(GSH/GST)的錶達。結果兩組耐藥細胞Bel-7402/DOXV 和Bel-7402/DOXL 對DOX、CD-DP均產生瞭交扠耐藥性,較親本Bel-7402 IC50值差異有統計學意義(P<0.01);較親本細胞的倍增時間明顯延長,分彆為65 h和46 h;較親本的DOX外排率明顯升高,分彆為81.06%、66.56%;兩組耐藥細胞P-gp、MRP錶達較親本細胞顯著提高( P<0.01),而GSH/GST的錶達無明顯變化。結論兩種方法建立的耐藥細胞繫模型均有穩定的耐藥性。肝髒移植法更能高度模擬人肝癌,它是具有近似人肝癌生物學和抗癌藥物動力學特徵的較理想模型。
목적:비교체외농도제도체증유도화라서간장이식유도량충방법건립인간암다약내약세포계Bel-7402/다유비성( Doxorubicin ,DOX)모형적생물학특성。방법분별채용체외농도제도체증유도화라서간장이식유도건립인간암다유비성다약내약세포아계Bel-7402/DOXV 화Bel-7402/DOXL 후,이용상차현미경관찰세포,MTT법검측량충세포적내약성,세포계수법회제생장곡선병용공식법계산배증시간,류식세포의측정세포DOX적섭입화외배이급P당단백( P-gp)、다약내약상관단백(MRP)、곡광감태류전매계통(GSH/GST)적표체。결과량조내약세포Bel-7402/DOXV 화Bel-7402/DOXL 대DOX、CD-DP균산생료교차내약성,교친본Bel-7402 IC50치차이유통계학의의(P<0.01);교친본세포적배증시간명현연장,분별위65 h화46 h;교친본적DOX외배솔명현승고,분별위81.06%、66.56%;량조내약세포P-gp、MRP표체교친본세포현저제고( P<0.01),이GSH/GST적표체무명현변화。결론량충방법건립적내약세포계모형균유은정적내약성。간장이식법경능고도모의인간암,타시구유근사인간암생물학화항암약물동역학특정적교이상모형。
Objective To compare the biological characteristics of two types of human hepatocellular carcinoma multi -drug re-sistant cell sub-lines Bel-7402/DOX models established by two methods .Methods We established human hepatocellular carcinoma doxorubicin multi-drug resistant cell sub-lines models Bel-7402/DOXV and Bel-7402/DOXL by in vitro concentration gradient in-creased induction and nude mice liver-implanted induction , respectively .Phase contrast microscopy was used to observe the cells and MTT ( methyl thiazolyl tetrazolium ) method was used to detect drug resistance of the two different sub-lines of cells .The ingestion and excretion of cellular doxorubicin (DOX) and the expression of P-glycoprotein (P-gp), multi-drug resistance-sociated protein (MRP) and glutathione S-transfer enzyme system ( GSH/GST ) were detected by flow cytometry .Results The Bel-7402/DOXV and Bel-7402/DOXL generated cross-resistance to DOX and CDDP ( cis-Diaminedichloroplatinum ) , they showed a significant difference in re-sistance to Bel-7402 IC50 value (P<0.01).The doubling times were significantly extended , compared with the parent cell line (39 h) , and were 65 h ( Bel-7402/DOXV) and 46 h ( Bel-7402/DOXL) .The excretion rates of DOX were significantly increased , com-pared with the parent cell (34.14%) line and were 81.06%(Bel-7402/DOXV) and 66.56%(Bel-7402/DOXL).Expressions of P-gp and MRP in the two groups of resistant sub-lines cells were significantly enhanced (P<0.01).There was no significant variation in the expression of GSH/GST (P>0.05).Conclusions Stable resistance is involved in the resistant cell line model established by the two methods above .Liver implantation is a good simulation of human hepatocellular and proves to be an ideal model with characteristics similar to human hepatocellular biology and the pharmacokinetics of anticancer drugs .